Finanse publiczne · 02/10/2023

IRS Proposes Excise Tax Regulations for Designated Drugs

The Internal Revenue Service (IRS) has released proposed regulations outlining the procedures for manufacturers, producers, and importers of certain designated drugs to report their liability for the excise tax imposed on these products, primarily affecting those sold during specific statutory periods, and exempting the tax from semimonthly deposit requirements.